Prolacta Bioscience Announces Study Published in Journal of Pediatrics Demonstrates Lower Incidence of Intestinal Disease in Preemies Fed Exclusive Human Milk Diet

Published: Aug 28, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

INDUSTRY, Calif.--(BUSINESS WIRE)--Prolacta Bioscience announces that results of the double-blind study just published in the Journal of Pediatrics demonstrate that extremely premature infants who are fed an exclusive human milk diet instead of preterm formula have a significantly lower incidence of surgery associated with the intestinal disease necrotizing enterocolitis (NEC) and require fewer days of intravenous feedings through total parenteral nutrition (TPN).

Help employers find you! Check out all the jobs and post your resume.

Back to news